Dr. Henry Yaggi, MD

NPI: 1801872510
Total Payments
$9,513
2022 Payments
$6,664
Companies
4
Transactions
8
Medicare Patients
164
Medicare Billing
$56,943

Payment Breakdown by Category

Other$5,408 (56.8%)
Research$3,950 (41.5%)
Food & Beverage$155.10 (1.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,408 3 56.8%
Unspecified $3,950 4 41.5%
Food and Beverage $155.10 1 1.6%

Payments by Type

General
$5,563
4 transactions
Research
$3,950
4 transactions

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $3,950 4 $0 (2022)
Merck Sharp & Dohme LLC $3,255 1 $0 (2022)
Boehringer Ingelheim International GmbH $2,153 2 $0 (2022)
Inspire Medical Systems, Inc. $155.10 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2022 $6,664 4 Merck Sharp & Dohme LLC ($3,255)
2021 $2,230 2 PFIZER INC. ($2,230)
2020 $463.42 1 Boehringer Ingelheim International GmbH ($463.42)
2018 $155.10 1 Inspire Medical Systems, Inc. ($155.10)

All Payment Transactions

8 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
07/22/2022 Boehringer Ingelheim International GmbH JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $1,689.30 General
Category: DIABETES
06/03/2022 Merck Sharp & Dohme LLC Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,255.00 General
03/14/2022 PFIZER INC. STEGLATRO (Drug) In-kind items and services $940.00 Research
Study: ERTUGLIFLOZIN CLINICAL PUBLICATION PROGRAM • Category: CARDIOVASCULAR
02/01/2022 PFIZER INC. STEGLATRO (Drug) In-kind items and services $780.00 Research
Study: ERTUGLIFLOZIN CLINICAL PUBLICATION PROGRAM • Category: CARDIOVASCULAR
10/22/2021 PFIZER INC. STEGLATRO (Drug) In-kind items and services $1,900.00 Research
Study: ERTUGLIFLOZIN CLINICAL PUBLICATION PROGRAM • Category: CARDIOVASCULAR
10/22/2021 PFIZER INC. STEGLATRO (Drug) In-kind items and services $330.00 Research
Study: ERTUGLIFLOZIN CLINICAL PUBLICATION PROGRAM • Category: CARDIOVASCULAR
12/08/2020 Boehringer Ingelheim International GmbH JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $463.42 General
Category: DIABETES
08/01/2018 Inspire Medical Systems, Inc. Inspire Upper Airway Stimulation System (Device) Food and Beverage Cash or cash equivalent $155.10 General
Category: Neurology

Research Studies & Clinical Trials

Study Name Company Amount Records
ERTUGLIFLOZIN CLINICAL PUBLICATION PROGRAM PFIZER INC. $3,950 4

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 54 94 $87,190 $14,477
2022 1 26 71 $78,455 $12,965
2021 2 41 70 $71,030 $12,645
2020 2 43 94 $96,550 $16,856
Total Patients
164
Total Services
329
Medicare Billing
$56,943
Procedure Codes
8

All Medicare Procedures & Services

8 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99291 Critical care, first 30-74 minutes Facility 2023 27 66 $75,250 $11,870 15.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 12 12 $5,940 $1,453 24.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 15 16 $6,000 $1,154 19.2%
99291 Critical care, first 30-74 minutes Facility 2022 26 71 $78,455 $12,965 16.5%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 25 54 $59,670 $10,102 16.9%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 16 16 $11,360 $2,543 22.4%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2020 31 82 $90,610 $15,758 17.4%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 12 12 $5,940 $1,099 18.5%

About Dr. Henry Yaggi, MD

Dr. Henry Yaggi, MD is a Geriatric Medicine healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801872510.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Henry Yaggi, MD has received a total of $9,513 in payments from pharmaceutical and medical device companies, with $6,664 received in 2022. These payments were reported across 8 transactions from 4 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($5,408).

As a Medicare-enrolled provider, Yaggi has provided services to 164 Medicare beneficiaries, totaling 329 services with total Medicare billing of $56,943. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.

Practice Information

  • Specialty Geriatric Medicine
  • Location New Haven, CT
  • Active Since 12/15/2005
  • Last Updated 04/07/2011
  • Taxonomy Code 207RG0300X
  • Entity Type Individual
  • NPI Number 1801872510

Products in Payments

  • STEGLATRO (Drug) $3,950
  • JARDIANCE (Drug) $2,153
  • Inspire Upper Airway Stimulation System (Device) $155.10

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Geriatric Medicine Doctors in New Haven